Prosecution Insights
Last updated: October 02, 2026
Application No. 18/563,509

SELECTIVE SEPARATION OF HEXACHLOROPLATINATE(IV) DIANIONS BASED ON EXO-BINDING WITH CUCURBIT[6]URIL

Non-Final OA §103§112
Filed
Nov 22, 2023
Priority
May 24, 2021 — provisional 63/202,038 +2 more
Examiner
CUTLIFF, YATE KAI RENE
Art Unit
Tech Center
Assignee
Northwestern University
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
1039 granted / 1302 resolved
+19.8% vs TC avg
Strong +24% interview lift
Without
With
+24.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 2m
Avg Prosecution
37 currently pending
Career history
1316
Total Applications
across all art units

Statute-Specific Performance

§101
3.9%
-36.1% vs TC avg
§103
38.8%
-1.2% vs TC avg
§102
13.0%
-27.0% vs TC avg
§112
34.3%
-5.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1302 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group II, claims 13 – 20 in the reply filed on August 7, 2026 is acknowledged. Claims 1 - 12 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on August 7, 2026. Status of Claims Claims 1 – 20 are pending. Claims 1 – 12 are withdrawn. Claim 13, 18 and 19 is objected. Claims 13 – 20 are rejected. Claim Objections Claim 13 is objected to because of the following informalities: “cucurbitrurial” in lines 2 and 3 is the incorrect spelling for “cucurbituril”. Appropriate correction is required. Claims 18 and 19 is objected to because of the following informalities: “cucurbitrurial” is the incorrect spelling for “cucurbituril”. Appropriate correction is required. Information Disclosure Statement The information disclosure statements (IDS) submitted on February 12, 2024 (8 pages) and February 12, 2024 (5 pages) were filed before the mailing date of the non-final office action. The submission is in compliance with the provisions of 37 CFR 1.97. However, the information disclosure statements filed February 12, 2024 (8 pages) and February 12, 2024 (5 pages) fails to comply with the provisions of 37 CFR 1.98 (b)(5) because each publication listed on the IDS is not identified by title. It has been placed in the application file, but the information referred to therein has not been considered as to the merits. For this reason those references have been lined through. Applicant is required to provide this information. 37 CFR 1.98 (b)(5). If an information disclosure statement does not comply with either §1.97 or §1.98 it will be placed in the file but will not be considered by the Office. Applicant is advised that the date of any re-submission of any item of information contained in this information disclosure statement or the submission of any missing element(s) will be the date of submission for purposes of determining compliance with the requirements based on the time of filing the statement, including all certification requirements for statements under 37 CFR 1.97(e). See MPEP § 609.05(a). Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 13 – 15 and 20 are rejected under 35 U.S.C. 112(b), as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, regards as the invention. Claims 13 – 15 and 20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being incomplete for omitting essential steps, such omission amounting to a gap between the steps. See MPEP § 2172.01. The omitted steps are: to recover the platinum metal from the CB[6]·H₂PtCl₆ microcrystals, the adducts were dispersed in an aqueous solution, and adding N₂H₄·H₂O, so as to reduce the [PtCl₆]²⁻ dianions down to platinum. (para. [0074]). Claim 13 is to a method for separation of a metal. The scope of claim 13 produces the CB[6]•H2PtCl6 microcrystals adduct. The specification under the heading “Platinum recovery and CB[6] regeneration” teaches: When an aqueous solution of CB[6] (1.0 mL, 10 mM) was mixed with equimolar amounts of [PtCl₆]²⁻, [PdCl₄]²⁻ and [RhCl₆]³⁻ anions, a yellow suspension formed immediately. The yellow solid (116.7 mg, Figure 7 (a)) was isolated by filtration, washing, and air drying. Subsequently, the yellow solid was dispersed in H2O (4 mL), and reduced by 78% N₂H₄·H₂O (1.0 mL). A black suspension was obtained after heating at 60 °C for 2 h with stirring. Following centrifugation and washing with 4 M HCl aqueous solution three times to dissolve the residual CB[6], black platinum metal (14.1 mg, Figure 7 (b)) was obtained. The above statements from the disclosure is an indication that Applicant that the reduction step was essential to obtain the metal. A broad range or limitation together with a narrow range or limitation that falls within the broad range or limitation (in the same claim) may be considered indefinite if the resulting claim does not clearly set forth the metes and bounds of the patent protection desired. See MPEP § 2173.05(c). In the present instance, claim 14 recites the broad recitation [PtX6]2- and X is a halogen, and the claim also recites optionally [PtCl6]2- which is the narrower statement of the range/limitation. The claim(s) are considered indefinite because there is a question or doubt as to whether the feature introduced by such narrower language is (a) merely exemplary of the remainder of the claim, and therefore not required, or (b) a required feature of the claims. For the propose of this rejection “optionally” in the claim is interpreted as “preferably or for example”. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 13 – 20 are is/are rejected under 35 U.S.C. 103 as being unpatentable over Ji et al. (European Journal of Inorganic Chemistry, vol. 2014, issue 9, 2014), in view of Rudnick et al. (Journal of the American Chemical Society, vol. 39, issue 4, 1917) and further in view of Wu et al. (Applied Materials & Interfaces, vol. 12, issue 34, 2020). The rejected claims cover, inter alia, a method for separation of a metal, the method comprising contacting a platinum halide dianion with a cucurbituril under conditions sufficient to cause co- precipitation of the platinum metal dianion and the cucurbituril. Dependent claim 14 further limits cucurbituril to cucurbitu[6]ril and the platinum halide dianion to [PtX6]2- and X a halogen. Dependent claims 15 – 19 further limit the process. Dependent claim 20 further limits the co-precipitation product of claim 13. However, Ji discloses the formation of a typical cucribit[6]uril (Q[6])-based porous material in the presence of hexachloroplatinate (IV) anon [PtCl6]2- as an inorganic structure inducer. (abstract). Further, Ji teaches: PNG media_image1.png 138 498 media_image1.png Greyscale The difference between Ji and the instantly claimed invention is as follows: contacting a platinum-bearing material with a hydrogen halide to form a metal-halide solution; reducing platinum of the precipitate with a reductant; isolating the platinum, isolating the cucurbituril; and recycling the isolated cucurbituril. Regarding contacting a platinum-bearing material with a hydrogen halide to form a metal-halide solution; the Examiner turns to the teaching of Rudnick. The prior art of Rudnick discloses the method for preparing hydrochloroplatinic acid (H2(PtCl6) for other purposed. (pp. 633, ln l). PNG media_image2.png 138 644 media_image2.png Greyscale Because the references teach methods for preparing hydrochloroplatinic acid that can be used from any purpose, it would have been obvious to one skilled in the art to substitute the K2PtCl6 of Rudnick in the process of Ji to achieve the predictable result of producing the Q[6]•[PtCl6]•2H3O•18H2O. Therefore, the claims would have been obvious because the substitution of one known element for another would have yielded predictable results to one of ordinary skill in the art at the time of the invention. KSR International Co. v. Teleflex Inc., 550 U.S. 398, 82 USPQ2d 1385 (U.S. 2007). Regarding reducing platinum of the precipitate with a reductant; isolating the platinum, isolating the cucurbituril; and recycling the isolated cucurbituril, the Examiner turns to the teaching of Wu. The prior art of Wu discloses high-efficiency gold recovery using cucurbit[6]uril. The process of Wu produced coprecipitate of CB[6]•HAuCl4 by a process similar to the process of Ji. (pp. B, left col. “Formation of Coprecipitates”). To recover the gold, following filtration of the CB[6]•HAuCl4 solid, the solid was dispersed in aqueous acid solution and reduced with N2H4•H2O. The gold metal was recovered from the dispersion by filtration. (pp. G, right col. middle of para. and Fig. 8). Also, the separated CB[6] can be reused after recrystallization. (pp. G, right col. middle of para. and Fig. 8). Based on the teaching above, wherein the process of Wu is similar to the process of Ji, in that it produces coprecipitate of gold anion halide and cucurbituril, it would have been obvious to one of ordinary skill in the art at the time the claimed invention was made to use a known technique as disclosed in Wu and obtain the platinum metal from the Q[6]•[PtCl6]•2H3O•18H2O of Ji by subjecting it to a reductant such as N2H4•H2O. Motivation can be found in the fact that in Wu the process reduces cost. Variations of particular work available in one field of endeavor may be prompted by design incentives and other market forces, either in same field or different one, and if person of ordinary skill in art can implement predictable variation, 35 U.S.C. §103 likely bars its patentability; similarly, if particular technique has been used to improve one device, and person of ordinary skill would recognize that it would improve similar devices in same way, then using that technique is obvious. KSR International co. v. Teleflex Inc., 550 U.S. at _____, 82 USPQ2D 1385 (U.S. 2007). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to YATE' K. CUTLIFF whose telephone number is (571)272-9067. The examiner can normally be reached Monday-Friday (8:30 - 5:30). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Y. Goon can be reached at (571) 270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /YATE' K CUTLIFF/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Nov 22, 2023
Application Filed
Sep 18, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747198
PHENOLIC ACID LIPID BASED CATIONIC LIPIDS
4y 0m to grant Granted Sep 29, 2026
Patent 12747256
METHOD FOR PRODUCING OXADISILACYCLOPENTANE COMPOUND
2y 10m to grant Granted Sep 29, 2026
Patent 12723014
REMOVAL OF SULFATE FROM MEG STREAMS USING CALCIUM CHLORIDE
2y 1m to grant Granted Sep 01, 2026
Patent 12715683
CONTAINER AND PROCESS FOR THE STORAGE OF A SATURATED ALIPHATIC C6-C12 CARBOXYLIC ACID
3y 4m to grant Granted Aug 25, 2026
Patent 12715835
BIORENEWABLE SYNTHESIS OF HYDROXY-HEXANOATE ESTERS
3y 0m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
99%
With Interview (+24.3%)
2y 2m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1302 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month